Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Boise Cascade
BCC
$2.65B
| $3.51M | ﹤0.01% |
125,000
-22,000
| -15% | -$571K |
|
2027
Verra Mobility
VRRM
$781M
| $3.51M | ﹤0.01% |
268,400
+223,900
| +503% | +$2.98M |
|
|
SPN
2028
DELISTED
Superior Energy Services, Inc.
SPN
| $3.5M | ﹤0.01% |
269,619
+118,110
| +78% | +$3.48M |
|
2029
FormFactor
FORM
$8.21B
| $3.48M | ﹤0.01% |
222,168
+83,800
| +61% | +$1.37M |
|
2030
Kimberly-Clark
KMB
$36.6B
| $3.48M | ﹤0.01% |
26,100
-28,100
| -52% | -$3.62M |
|
2031
Compass Diversified
CODI
$756M
| $3.48M | ﹤0.01% |
+182,023
| New | +$3.11M |
|
2032
Great Elm Group
GEG
$68.4M
| $3.48M | ﹤0.01% |
808,755
-1,454
| -0.2% | -$5.92K |
|
|
JT
2033
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $3.47M | ﹤0.01% |
116,125
+25,379
| +28% | +$939K |
|
2034
SouthState Bank Corp
SSB
$10.2B
| $3.47M | ﹤0.01% |
47,118
-79,349
| -63% | -$5.7M |
|
2035
iShares California Muni Bond ETF
CMF
$4.55B
| $3.47M | ﹤0.01% |
57,200
+18,400
| +47% | +$1.1M |
|
|
GDEN
2036
DELISTED
Golden Entertainment
GDEN
| $3.47M | ﹤0.01% |
247,700
+80,400
| +48% | +$1.17M |
|
|
TBI
2037
Trueblue
TBI
$222M
| $3.47M | ﹤0.01% |
157,200
+63,200
| +67% | +$1.47M |
|
|
AEL
2038
DELISTED
American Equity Investment Life Holding Company
AEL
| $3.46M | ﹤0.01% |
127,200
-3,800
| -3% | -$109K |
|
2039
S&T Bancorp
STBA
$1.88B
| $3.45M | ﹤0.01% |
92,000
+35,300
| +62% | +$1.37M |
|
2040
Cedar Fair
FUN
$1.81B
| $3.44M | ﹤0.01% |
72,150
-113,500
| -61% | -$5.88M |
|
2041
Lexicon Pharmaceuticals
LXRX
$1.04B
| $3.44M | ﹤0.01% |
546,741
+57,228
| +12% | +$343K |
|
|
RVI
2042
DELISTED
Retail Value Inc. Common Shares
RVI
| $3.44M | ﹤0.01% |
+1,076,368
| New | +$3.31M |
|
2043
International Bancshares
IBOC
$4.75B
| $3.43M | ﹤0.01% |
91,000
-91,937
| -50% | -$3.61M |
|
2044
ICF International
ICFI
$1.46B
| $3.43M | ﹤0.01% |
+47,113
| New | +$3.53M |
|
2045
Friedman Industries
FRD
$242M
| $3.43M | ﹤0.01% |
492,620
-4,400
| -0.9% | -$32.3K |
|
2046
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
| $3.42M | ﹤0.01% |
67,858
+15,958
| +31% | +$797K |
|
2047
Domo
DOMO
$174M
| $3.39M | ﹤0.01% |
+124,200
| New | +$4.32M |
|
|
AIFU
2048
AIFU Inc
AIFU
$209M
| $3.38M | ﹤0.01% |
253
+179
| +242% | +$2.04M |
|
2049
Cathay General Bancorp
CATY
$4.21B
| $3.38M | ﹤0.01% |
94,071
-110,700
| -54% | -$3.93M |
|
2050
First American
FAF
$7.71B
| $3.38M | ﹤0.01% |
62,900
-542,400
| -90% | -$29.5M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.